Drug Trial Radar · NCT00004838
Randomized Study of Succimer (Dimercaptosuccinic Acid) on Growth of Lead-Poisoned Children
Last checked: Nov 20, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
175
Actual
Start
Sep 1997
Primary completion
Not stated
Study completion Jul 1998
Sponsor
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
- Sponsor type
- NIH
- Collaborators
- Nationwide Children's Hospital
- First posted
- Feb 25, 2000
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- All sexes, from 0 years, up to 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
OBJECTIVES: Compare growth of lead-poisoned children receiving succimer (dimercaptosuccinic acid; DMSA) plus standard treatment to those receiving standard treatment only.
Conditions
- Lead Poisoning
Interventions
succimerDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.